Warrior Chiggerex Relief

Manufacturer
Derma Care Research Labs, LLC
Effective date
2024-12-15
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:43:46

Label at a glance#

ProductWarrior Chiggerex Relief
Active ingredientBENZOCAINE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Benzocaine 10%

OTC - PURPOSE SECTION

Pain Relief

DOSAGE & ADMINISTRATION SECTION

Uses: for the temporary relief of pain and itching associated with chigger bites, red bug bites, ticks, and mosquito bites.

WARNINGS SECTION

For external use only.

When using this product avoid contact with eyes. Stop use and ask a doctor if the condition worsens, symptoms persist for more than 7 days or clear up and occur again within a few days.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

INDICATIONS & USAGE SECTION

Adults and children 2 years and older: apply to the affected area, not more than 3 to 4 times daily. Children under 2 years of age: ask a doctor.

INACTIVE INGREDIENT SECTION

Ascorbic Acid, Aloe Barbadensis Leaf Extract, Camphor, Chamomilla Recutita (Matricaria) Flower Extract, Cholecalciferol, Diazolidinyl Urea, Disodium EDTA, Eugenia Caryophyllus (Clove) Flower Oil, Fragrance, Mentha Piperita (Peppermint) Oil, Methylparaben, Octyldodecanol, Olea Europaea (Olive) Fruit Extract, PEG-2 Stearate, PEG-2 Stearate SE, PEG-8 Dimethicone, Propylene Glycol, Propylparaben, Pyridoxine HCl, Retinyl Palmitate, Silica, Sodium Propoxyhydroxypropyl Thiosulfate Silica, Tocopheryl Acetate, Water, Zea Mays (Corn) Oil.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
244550benzocaine 10 % Topical CreamPSN2
244550benzocaine 100 MG/ML Topical CreamSCD2
244550benzocaine 10 % Topical CreamSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ebc62596-fc97-4d03-9483-7ba095d25db7Product name120151210
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72839-069-01Warrior Chiggerex Relief50 g in 1 JARCREAM502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72839-069WARRIOR CHIGGEREX RELIEF (BENZOCAINE 10%) CREAM [DERMA CARE RESEARCH LABS, LLC]2Current NDC, Legacy NDC, 1 package rows20241217_dcf2f52b-2295-58e5-e053-2995a90a7fd8.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72839-06972839-069-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Warrior Chiggerex ReliefBENZOCAINE 10%Derma Care Research Labs, LLCdcf2f52b-2295-58e5-e053-2995a90a7fd82024-12-15WarningsExact identifier
ndc (package): 72839-069-01
ndc (product): 72839-069
ndc11 (package): 72839006901
spl id: 295941e8-0c66-8b8f-e063-6394a90aac09
spl set id: dcf2f52b-2295-58e5-e053-2995a90a7fd8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.